Kohara M - Search Results

1

Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial.

Kimura K, Ikoma A, Shibakawa M, Shimoda S, Harada K, Saio M, Imamura J, Osawa Y, Kimura M, Nishikawa K, Okusaka T, Morita S, Inoue K, Kanto T, Todaka K, Nakanishi Y, Kohara M, Mizokami M. Kimura K, et al. Among authors: kohara m. EBioMedicine. 2017 Sep;23:79-87. doi: 10.1016/j.ebiom.2017.08.016. Epub 2017 Aug 19. EBioMedicine. 2017. PMID: 28844410 Free PMC article. Clinical Trial.

2

Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics.

Kohara M, Tanaka T, Tsukiyama-Kohara K, Tanaka S, Mizokami M, Lau JY, Hattori N. Kohara M, et al. J Infect Dis. 1995 Oct;172(4):934-8. doi: 10.1093/infdis/172.4.934. J Infect Dis. 1995. PMID: 7561212 Clinical Trial.

3

Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes.

Orito E, Mizokami M, Tanaka T, Lau JY, Suzuki K, Yamauchi M, Ohta Y, Hasegawa A, Tanaka S, Kohara M. Orito E, et al. Among authors: kohara m. Gut. 1996 Dec;39(6):876-80. doi: 10.1136/gut.39.6.876. Gut. 1996. PMID: 9038674 Free PMC article.

4

Acute hepatitis caused by sexual or household transmission of GBV-C.

Tanaka T, Takeuchi T, Inoue K, Tanaka S, Kohara M. Tanaka T, et al. Among authors: kohara m. J Hepatol. 1997 Dec;27(6):1110-2. doi: 10.1016/s0168-8278(97)80156-0. J Hepatol. 1997. PMID: 9453438

5

Real-time detection system for quantification of hepatitis C virus genome.

Takeuchi T, Katsume A, Tanaka T, Abe A, Inoue K, Tsukiyama-Kohara K, Kawaguchi R, Tanaka S, Kohara M. Takeuchi T, et al. Among authors: kohara m. Gastroenterology. 1999 Mar;116(3):636-42. doi: 10.1016/s0016-5085(99)70185-x. Gastroenterology. 1999. PMID: 10029622

6

Possible association between serum GB virus C RNA level and disease activity in fulminant hepatitis type G.

Inoue K, Yoshiba M, Sekiyama K, Kohara M. Inoue K, et al. Among authors: kohara m. J Hepatol. 1999 May;30(5):801-6. doi: 10.1016/s0168-8278(99)80132-9. J Hepatol. 1999. PMID: 10365805

7

Hepatitis C virus replication and pathogenesis.

Kohara M. Kohara M. J Dermatol Sci. 2000 Apr;22(3):161-8. doi: 10.1016/s0923-1811(99)00082-1. J Dermatol Sci. 2000. PMID: 10698153 Review.

8

Adenovirus-mediated gene transfer of interferon alpha improves dimethylnitrosamine-induced liver cirrhosis in rat model.

Suzuki K, Aoki K, Ohnami S, Yoshida K, Kazui T, Kato N, Inoue K, Kohara M, Yoshida T. Suzuki K, et al. Among authors: kohara m. Gene Ther. 2003 May;10(9):765-73. doi: 10.1038/sj.gt.3301949. Gene Ther. 2003. PMID: 12704415

9

Adenovirus-mediated gene transfer of interferon alpha inhibits hepatitis C virus replication in hepatocytes.

Suzuki K, Aoki K, Ohnami S, Yoshida K, Kazui T, Kato N, Inoue K, Kohara M, Yoshida T. Suzuki K, et al. Among authors: kohara m. Biochem Biophys Res Commun. 2003 Aug 8;307(4):814-9. doi: 10.1016/s0006-291x(03)01255-5. Biochem Biophys Res Commun. 2003. PMID: 12878183

10

Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.

Tanaka T, Inoue K, Hayashi Y, Abe A, Tsukiyama-Kohara K, Nuriya H, Aoki Y, Kawaguchi R, Kubota K, Yoshiba M, Koike M, Tanaka S, Kohara M. Tanaka T, et al. Among authors: kohara m. J Med Virol. 2004 Feb;72(2):223-9. doi: 10.1002/jmv.10566. J Med Virol. 2004. PMID: 14695663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters